Epperly Melissa B, Insider Trading -- Recent SEC Form 4 Transactions
Epperly Melissa B, (CIK 1807359) reported 20 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-10-05). Recent activity: Buy ROIV (17,750 shares), Sell ROIV (16,850 shares), Sell ROIV (900 shares), Buy ROIV (5,054 shares), Sell ROIV (4,338 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 17,750 | $79,165 |
| 2026-10-05 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 16,850 | $607,948 |
| 2026-10-05 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 900 | $32,913 |
| 2026-09-18 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 5,054 | $0 |
| 2026-09-17 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 4,338 | $172,002 |
| 2026-09-17 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 600 | $24,228 |
| 2026-09-14 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 2,179 | $89,208 |
| 2026-07-21 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 543 | $0 |
| 2026-07-01 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 17,750 | $79,165 |
| 2026-07-01 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 15,002 | $514,869 |
| 2026-07-01 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 2,748 | $95,383 |
| 2026-04-21 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 670 | $0 |
| 2026-03-18 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 41,861 | $1.2M |
| 2026-01-22 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 815 | $0 |
| 2026-01-22 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 54 | $1,241 |
| 2025-10-22 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 1,056 | $0 |
| 2025-09-12 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 14,524 | $0 |
| 2025-09-12 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 1,661 | $22,872 |
| 2025-07-21 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 1,609 | $0 |
| 2025-04-21 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 1,847 | $0 |
Source: SEC Form 4 filings · as of 2026-10-05